Walmart announces the launch of its own analog insulin

Walmart has announced the launch of its private brand of analog insulin through the ReliOn brand. The vials will be available for $72.88, while FlexPen will be available for $85.88 by prescription. “We know many people with diabetes struggle to manage the financial burden of this condition, and we are focused on helping by providing affordable solutions,” said Dr. Cheryl Pegus, executive vice president of Walmart Health & Wellness. For more details, click here …

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org